Assessment of the Efficacy of Carnipure® AAS on Body Composition, Muscle Thickness, and Strength Adaptations in Healthy Men

Inclusion Criteria:

• Healthy male subjects 18-40 years old

• Recreationally trained (<1-year of training experience)

• Not currently consuming any ergogenic supplements or performance enhancing drugs

• Body mass index (BMI) 18-35 kg/m2

• No recent injuries that would contraindicate participation in a resistance trainingprogram

• Willing and able to give written informed consent

• Able to read, understand, sign and date the informed consent document (English only)

• Able and willing to comply with the schedule visit(s) and study requirements.

Exclusion Criteria:

• Currently taking (within the past 30 days) ergogenic dietary supplements including,creatine, protein, amino acids, or stimulants other than caffeine (yohimbe,ephedrine, etc.)

• Currently taking performance enhancing drugs (testosterone or otheranabolic-androgenic steroids), human growth hormone, insulin, etc.

• History or current malignancy

• Receiving chemotherapy agents or radiation treatments

• Musculoskeletal disease (muscular dystrophy, arthritis, etc.)

• Recent (<3-months) musculoskeletal injuries

• BMI <18 or >5 kg/m2

• Diagnosis of a terminal illness

• Use of prescription medications that influence muscle anabolism (i.e., prescriptionhormone therapies, etc.)

• History of alcohol abuse

• History or current drug abuse

• History or current cigarette smoke (including vaping) within the past 14 days fromthe screening visit

• Insulin-dependent diabetes and/or metformin use

• Chronic kidney or liver disease

• Has significant concurrent illnesses (controlled or uncontrolled), such as diabetes,lupus, epilepsy, or cardiac disorders, hepatitis B/C, HIV, serious mental healthillness such as dementia or schizophrenia; psychiatric hospitalization in the pasttwo years, or other, which in the opinion of the investigator, such conditions mightbe aggravated as a result of treatment

• The investigator feels that for any reason the subject is not eligible toparticipate in the study

• History of uncontrolled cardiovascular disease (i.e., myocardial infarction,hypertension, hypercholesterolemia, peripheral vascular disease, other)

• Developmental disability or cognitive impairment that would preclude adequatecomprehension of the informed consent form and/or ability to follow study subjectrequirement and/or record the necessary study measurements

• A family member of the investigator or an employee of the investigator

• Participation in any other investigational study within 30 days prior to consent.